Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system
CA 2474138 A1 · Owner: Vanderbilt University · Inventors: Hallahan, Dennis E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A halogen-labeled gene therapy construct that includes halogen labeled nucleic acids, methods for preparing a halogenated gene therapy construct and methods , for in vivo imaging of the same. Also provided are methods for non-invasive drug detection in a subject using a labeled antibody that recognizes a heterologous antigen conjugated to, encoded by or otherwise associated with , the drug.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 15, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 15, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 15, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.